BALPHARMA

Bal Pharma Shareholding Pattern

₹97.90-3.51%
Market cap
₹156 crore
P/E
21.6
P/B
1.90
ROE
7.9%
Dividend yield
1.23%

As of 30-JUN-2026, promoters held 50.86% of Bal Pharma (0.00 pp from 31-MAR-2026), foreign institutional investors 0.15% and the public 48.99%.

Bal Pharma shareholding pattern

Percentage of shares held, by quarter, newest first.

Bal Pharma shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters50.86%50.86%50.86%50.86%50.86%n/a0.00 pp
Foreign institutions (FII/FPI)0.15%0.14%0.14%0.22%0.15%n/a+0.01 pp
Public48.99%49.01%49.01%48.92%48.99%n/a-0.02 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Bal Pharma shareholding pattern — frequently asked questions

What is the promoter holding in Bal Pharma?

Promoters held 50.86% of Bal Pharma as of 30-JUN-2026, unchanged from 50.86% in 31-MAR-2026.

How much do FIIs hold in Bal Pharma?

Foreign institutional investors held 0.15% of Bal Pharma as of 30-JUN-2026, a change of +0.01 pp from the previous quarter.

Who owns Bal Pharma?

As of 30-JUN-2026, Bal Pharma's shareholders were promoters (50.86%), foreign institutional investors 0.15% and the public 48.99%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade Bal Pharma With ATS

Track BALPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Bal Pharma share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.